China Names HIV Drugs in Treatment Plan for New Virus
Restaurant workers wear surgical masks on Lunar New Year’s eve on D’Aguilar street in the Central district of Hong Kong, China. (Photographer: Ivan Abreu/Bloomberg)  

China Names HIV Drugs in Treatment Plan for New Virus

(Bloomberg) -- China is using AbbVie Inc’s HIV drugs as an ad-hoc treatment for pneumonia caused by the novel coronavirus while the global search for a cure continues.

The Beijing branch of China’s National Health Commission said that a combination of lopinavir and ritonavir, sold under the brand name Kaletra by AbbVie, is part of its latest treatment plan for patients infected by the virus, which has killed at least 56 people in China and sickened more than 2,000 worldwide.

The NHC said that while there is not yet any effective anti-viral drug, it recommends patients are given two lopinavir and ritonavir tablets twice a day and a dose of alpha-interpheron through nebulization twice daily.

China Names HIV Drugs in Treatment Plan for New Virus

Medical journal Lancet said on Friday that a clinical trial is under way using ritonavir and lopinavir to treat cases of the new coronavirus. Meanwhile, China’s Center for Disease Control and Prevention will start developing a vaccine, according to the Global Times.

Wang Guangfa, a respiratory expert at Peking University First Hospital in Beijing who was infected by the virus after visiting Wuhan to inspect to coronavirus patients, told China News Week earlier this week that his doctor recommended he take the HIV drugs to fight the new virus and they worked on him.

©2020 Bloomberg L.P.

Also read: Emerging Markets on Edge as Viral Outbreak Spreads from China

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.